Free Trial

XBiotech (XBIT) Short Interest Ratio & Short Volume

XBiotech logo
$2.93 -0.11 (-3.62%)
Closing price 05/1/2025 04:00 PM Eastern
Extended Trading
$3.00 +0.07 (+2.56%)
As of 04:36 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

XBiotech Short Interest Data

XBiotech (XBIT) has a short interest of 697,600 shares, representing 3.58% of the float (the number of shares available for trading by the public). This marks a -9.86% decrease in short interest from the previous month. The short interest ratio (days to cover) is 13.2, indicating that it would take 13.2 days of the average trading volume of 75,250 shares to cover all short positions.

Current Short Interest
697,600 shares
Previous Short Interest
773,900 shares
Change Vs. Previous Month
-9.86%
Dollar Volume Sold Short
$2.22 million
Short Interest Ratio
13.2 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
30,488,000 shares
Float Size
19,500,000 shares
Short Percent of Float
3.58%
Today's Trading Volume
56,643 shares
Average Trading Volume
75,250 shares
Today's Volume Vs. Average
75%
Short Selling XBiotech?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for XBiotech and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

XBIT Short Interest Over Time

XBIT Days to Cover Over Time

XBIT Percentage of Float Shorted Over Time

XBiotech Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/2025697,600 shares $2.22 million -9.9%3.6%13.2 $3.18
3/31/2025773,900 shares $2.51 million -3.3%4.0%14.6 $3.24
3/15/2025800,100 shares $2.65 million -23.1%4.1%12.6 $3.31
2/28/20251,040,000 shares $3.66 million +13.9%5.3%15.1 $3.52
2/15/2025912,900 shares $2.99 million +0.6%4.7%13.1 $3.27
1/31/2025907,400 shares $3.14 million +15.2%4.7%12.7 $3.46
1/15/2025787,900 shares $3.06 million +2.2%4.0%11.5 $3.89
12/31/2024770,700 shares $3.04 million -0.6%3.9%11.7 $3.95
12/15/2024775,200 shares $5.39 million -3.6%3.9%13.1 $6.95
11/30/2024803,800 shares $6.12 million -5.3%4.1%16.2 $7.61
11/15/2024848,300 shares $5.65 million No Change4.3%17.9 $6.66
10/31/2024848,300 shares $6.16 million -6.3%4.3%17.7 $7.26
10/15/2024904,900 shares $6.74 million -2.2%4.6%18.4 $7.45
9/30/2024925,400 shares $7.15 million +6.9%4.7%15.6 $7.73
9/15/2024865,600 shares $6.11 million +1.6%4.4%7.9 $7.06
8/31/2024852,300 shares $5.45 million -5.8%4.3%6.9 $6.40
8/15/2024904,500 shares $5.76 million -3.6%4.6%7 $6.37
7/31/2024937,800 shares $7.24 million -0.9%4.8%7.3 $7.72
7/15/2024946,100 shares $5.95 million +68.0%4.8%7.2 $6.29
6/30/2024563,100 shares $2.89 million -14.3%2.9%4.2 $5.14
6/15/2024657,300 shares $4.01 million -0.8%3.3%6.7 $6.10
5/31/2024662,500 shares $4.80 million -0.9%3.4%8.3 $7.25
5/15/2024668,500 shares $5.74 million -5.8%3.7%9.1 $8.59
4/30/2024709,900 shares $5.44 million +5.9%3.9%9.1 $7.67
4/15/2024670,600 shares $6.31 million +10.9%3.4%9.4 $9.41
3/31/2024604,500 shares $4.91 million +3.3%3.1%10 $8.13
3/15/2024585,300 shares $3.46 million +8.9%3.0%12.8 $5.91
2/29/2024537,500 shares $3.36 million +35.4%2.7%14.6 $6.26
2/15/2024397,000 shares $2.29 million +5.4%2.0%12.1 $5.78
1/31/2024376,500 shares $1.73 million +9.6%1.9%15.5 $4.59
1/15/2024343,500 shares $1.72 million +1.2%1.7%16.8 $5.00
12/31/2023339,400 shares $1.36 million -0.6%1.7%18.9 $4.00
12/15/2023341,500 shares $1.59 million -0.2%1.7%19 $4.65
11/30/2023342,300 shares $1.34 million +9.5%1.8%21.1 $3.92
11/15/2023312,500 shares $1.19 million +6.1%1.7%17.2 $3.80
10/31/2023294,500 shares $1.23 million -1.3%1.6%16.5 $4.18
10/15/2023298,500 shares $1.17 million +7.7%1.6%17.5 $3.93
9/30/2023277,200 shares $1.14 million +9.0%1.5%15.5 $4.12
9/15/2023254,400 shares $1.16 million +72.4%1.4%11.9 $4.55
8/31/2023147,600 shares $726,192.00 -11.9%0.8%5 $4.92
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.

Click here to access the full report now.
8/15/2023167,600 shares $812,860.00 +9.9%0.9%3.5 $4.85
7/31/2023152,500 shares $767,075.00 -5.8%0.8%1.8 $5.03
7/15/2023161,900 shares $841,880.00 -0.6%0.9%1.8 $5.20
6/30/2023162,800 shares $967,032.00 +4.6%0.9%1.8 $5.94
6/15/2023155,600 shares $955,384.00 +79.1%0.8%1.7 $6.14
5/31/202386,900 shares $442,755.50 +3.7%0.5%1.1 $5.10
5/15/202383,800 shares $279,892.00 +23.1%0.5%1.2 $3.34
4/30/202368,100 shares $234,264.00 -5.0%0.4%2.3 $3.44
4/15/202371,700 shares $255,252.00 -10.0%0.4%2.4 $3.56
3/31/202379,700 shares $274,965.00 +12.7%0.5%2.5 $3.45
3/15/202370,700 shares $238,966.00 -15.0%0.4%2 $3.38
2/28/202383,200 shares $279,552.00 +22.5%0.5%2.1 $3.36
2/15/202367,900 shares $249,193.00 -6.1%0.4%1.7 $3.67
1/31/202372,300 shares $314,505.00 -9.7%0.4%1.9 $4.35
1/15/202380,100 shares $373,266.00 +0.8%0.5%2.1 $4.66
12/30/202279,500 shares $279,045.00 -22.1%0.5%2.1 $3.51
12/15/2022102,000 shares $332,520.00 -27.2%0.6%2.8 $3.26
11/30/2022140,100 shares $453,924.00 +16.9%0.9%3.9 $3.24
11/15/2022119,800 shares $433,676.00 +24.7%0.8%3 $3.62
10/31/202296,100 shares $337,311.00 +42.4%0.6%2.2 $3.51
10/15/202267,500 shares $247,050.00 -11.0%0.4%1.4 $3.66
9/30/202275,800 shares $274,396.00 +9.9%0.5%1.6 $3.62
9/15/202269,000 shares $280,830.00 -22.2%0.4%0.8 $4.07
8/31/202288,700 shares $355,687.00 +9.1%0.6%0.9 $4.01
8/15/202281,300 shares $413,817.00 +89.5%0.5%0.7 $5.09
7/31/202242,900 shares $221,793.00 -15.6%0.3%0.3 $5.17
7/15/202250,800 shares $265,176.00 -21.0%0.3%0.4 $5.22
6/30/202264,300 shares $362,009.00 -89.1%0.4%0.5 $5.63
6/15/2022589,100 shares $3.33 million +1.9%3.9%4.2 $5.66
5/31/2022578,100 shares $3.18 million -6.6%3.8%5.8 $5.50
5/15/2022619,000 shares $3.56 million +13.2%4.1%6.9 $5.75
4/30/2022546,900 shares $4.24 million +15.5%3.6%7.1 $7.76
4/15/2022473,600 shares $3.95 million -19.2%3.1%7.7 $8.33
3/31/2022585,900 shares $5.06 million +1.6%3.9%10.1 $8.64
3/15/2022576,800 shares $5.20 million +7.4%3.8%10.4 $9.01
2/28/2022536,900 shares $5.29 million -6.9%3.6%8.5 $9.86
2/15/2022576,400 shares $5.90 million +2.8%3.8%9 $10.23
1/31/2022560,800 shares $6.04 million +0.9%3.4%8.4 $10.77
1/15/2022556,100 shares $6.45 million -4.8%3.3%8.3 $11.60
12/31/2021584,100 shares $6.50 million -13.0%N/A8.5 $11.13
12/15/2021671,100 shares $7.62 million -2.1%3.6%8.7 $11.35
11/30/2021685,200 shares $8.65 million -3.2%3.7%9.9 $12.62
11/15/2021708,000 shares $9.61 million -1.5%3.8%11 $13.57
10/29/2021719,000 shares $10.54 million -0.2%3.8%12.1 $14.66
10/15/2021720,600 shares $9.52 million -0.2%3.9%12.6 $13.21
9/30/2021721,700 shares $9.35 million -4.2%3.9%9.7 $12.95
9/15/2021753,100 shares $11.88 million -1.1%4.1%9.6 $15.77
8/31/2021761,400 shares $12.16 million +3.2%4.2%9.2 $15.97
8/13/2021737,900 shares $11.78 million -2.5%4.1%8.4 $15.96
7/30/2021756,400 shares $12.25 million -8.3%4.2%8.5 $16.20
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.

Click here to access the full report now.
7/15/2021825,200 shares $13.67 million -8.0%4.6%8.9 $16.57
6/30/2021897,300 shares $14.86 million -14.5%5.0%11.4 $16.56
6/15/20211,050,000 shares $17.08 million -10.3%5.9%15.4 $16.27
5/28/20211,170,000 shares $20.18 million -6.4%6.6%17.9 $17.25
5/14/20211,250,000 shares $21.40 million -5.3%7.1%18.2 $17.12
4/30/20211,320,000 shares $23.52 million -6.4%7.5%16.9 $17.82
4/15/20211,410,000 shares $23.81 million -1.4%8.2%14.7 $16.89
3/31/20211,430,000 shares $24.24 million No Change8.3%13.2 $16.95
3/15/20211,430,000 shares $28.54 million -4.7%8.1%12.7 $19.96
2/26/20211,500,000 shares $28.41 million -3.2%8.5%14 $18.94
2/12/20211,550,000 shares $31.12 million -4.3%8.8%13.6 $20.08
1/29/20211,620,000 shares $29.34 million -1.2%9.2%14.8 $18.11
1/15/20211,640,000 shares $27.70 million -0.6%9.3%15.9 $16.89
12/31/20201,650,000 shares $26.30 million -2.9%9.4%18.8 $15.94
12/15/20201,700,000 shares $32.18 million No Change10.3%19.6 $18.93
11/30/20201,700,000 shares $32.96 million +0.6%11.2%16.6 $19.39
10/30/20201,820,000 shares $31.78 million -1.1%12.6%12 $17.46
10/15/20201,840,000 shares $35.75 million +4.0%12.7%11.3 $19.43
9/30/20201,770,000 shares $33.79 million -11.5%12.2%9.2 $19.09
9/15/20202,000,000 shares $39.66 million -2.0%14.3%9.7 $19.83
8/31/20202,040,000 shares $38.60 million +9.7%14.6%10.2 $18.92
8/14/20201,860,000 shares $31.99 million -5.6%13.3%9.3 $17.20
7/31/20201,970,000 shares $28.64 million -8.8%14.2%11.2 $14.54
7/15/20202,160,000 shares $32.70 million -2.3%15.5%10.6 $15.14
6/30/20202,210,000 shares $31.71 million +11.6%15.9%11.2 $14.35
6/15/20201,980,000 shares $26.81 million -6.6%14.2%8.7 $13.54
5/29/20202,120,000 shares $30.10 million +4.4%15.2%7.4 $14.20
5/15/20202,030,000 shares $29.03 million -8.6%14.6%6 $14.30

XBIT Short Interest - Frequently Asked Questions

What is XBiotech's current short interest?

Short interest is the volume of XBiotech shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 697,600 shares of XBIT short. 3.58% of XBiotech's shares are currently sold short. Learn More on XBiotech's current short interest.

What is a good short interest ratio for XBiotech?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XBIT shares currently have a short interest ratio of 13.0. Learn More on XBiotech's short interest ratio.

Which institutional investors are shorting XBiotech?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of XBiotech: Group One Trading LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for XBiotech?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.58% of XBiotech's floating shares are currently sold short.

Is XBiotech's short interest increasing or decreasing?

XBiotech saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 697,600 shares, a decrease of 9.9% from the previous total of 773,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is XBiotech's float size?

XBiotech currently has issued a total of 30,488,000 shares. Some of XBiotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. XBiotech currently has a public float of 19,500,000 shares.

How does XBiotech's short interest compare to its competitors?

3.58% of XBiotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to XBiotech: Arcturus Therapeutics Holdings Inc. (20.80%), Checkpoint Therapeutics, Inc. (7.24%), Allogene Therapeutics, Inc. (20.67%), Olema Pharmaceuticals, Inc. (13.17%), Entrada Therapeutics, Inc. (5.00%), Benitec Biopharma Inc. (1.24%), Cartesian Therapeutics, Inc. (28.47%), Monte Rosa Therapeutics, Inc. (16.37%), ProKidney Corp. (14.50%), Atai Life Sciences (8.91%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short XBiotech stock?

Short selling XBIT is an investing strategy that aims to generate trading profit from XBiotech as its price is falling. XBIT shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against XBiotech?

A short squeeze for XBiotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of XBIT, which in turn drives the price of the stock up even further.

How often is XBiotech's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XBIT, twice per month. The most recent reporting period available is April, 15 2025.




This page (NASDAQ:XBIT) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners